CytomX Therapeutics, Inc. (CTMX)

NASDAQ: CTMX · Real-Time Price · USD

4.120

-0.170 (-3.96%)

At close: Apr 28, 2026, 4:00 PM EDT

4.120

0.00 (0.00%)

After-hours: Apr 28, 2026, 4:54 PM EDT

CytomX Therapeutics Employees

CytomX Therapeutics had 69 employees as of December 31, 2025. The number of employees decreased by 52 or -42.98% compared to the previous year.

Employees

Change (1Y)

-52

Growth (1Y)

-42.98%

Revenue / Employee

$1,104,362

Profits / Employee

-$295,217

Market Cap

896.90M

Employees Chart

Date	Employees	Change	Growth
Dec 31, 2025	69	-52	-42.98%
Dec 31, 2024	121	-1	-0.82%
Dec 31, 2023	122	4	3.39%
Dec 31, 2022	118	-60	-33.71%
Dec 31, 2021	178	32	21.92%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Company Name	Employees
Fortrea Holdings	14,300
Maravai LifeSciences Holdings	435
Phathom Pharmaceuticals	371
KalVista Pharmaceuticals	275
Xencor	260
Geron	258
Omeros	175
Janux Therapeutics	109